Sector Vertex Pharmaceuticals Incorporated

Aandelen

VRTX

US92532F1003

Farmaceutische producten

Geschatte realtime 18:55:42 12-11-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
544,64 USD -0,44% Intraday-grafiek van Vertex Pharmaceuticals Incorporated +0,34% +20,07%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
-0,44%+0,34%+7,37%+3,54%+20,07%+25,37%+43,66%+190,65%+476,53% 139 mld.
+0,56%+6,10%+22,44%+18,66%+34,74%+42,27%+136,33%+457,68%+1.780,04% 1.280 mld.
+1,54%+4,77%+8,18%+9,37%+37,86%+46,77%+93,26%+72,90%+144,69% 675 mld.
+0,45%+2,93%+5,54%+19,26%+29,84%+27,20%+113,99%+153,64%+371,14% 521 mld.
+1,14%+3,78%+12,92%+11,22%+23,86%+39,98%+70,26%+10,16%+74,09% 386 mld.
+0,88%+1,46%+2,50%+12,16%+41,63%+63,02%+45,49%+77,48%+134,66% 363 mld.
+1,11%+0,07%+11,89%+8,07%+22,46%+28,19%+58,61%+76,10%+86,03% 301 mld.
+0,24%-0,80%+15,83%+19,04%+1,02%+3,05%+35,93%+58,28%+219,09% 286 mld.
+0,61%+2,36%+12,83%+13,21%+43,95%+40,11%+76,67%+122,89%+221,79% 253 mld.
+0,30%+1,75%+13,34%+25,49%+38,91%+38,17%+127,54%+152,67%+122,15% 211 mld.
+1,12%+1,66%+7,55%-7,93%-15,22%-14,11%-60,24%-24,79%+141,15% 178 mld.
-0,80%-2,11%+2,99%+11,17%+17,47%+13,07%+0,93%-41,18%-9,67% 168 mld.
+0,18%-0,17%+9,45%-1,07%+16,83%+28,40%+25,66%+6,04%+11,42% 129 mld.
+0,04%+0,95%+13,22%+23,15%+31,92%+28,71%+129,93%+381,32%+653,11% 125 mld.
+1,58%+4,08%+22,88%+16,65%+6,36%-2,39%+3,15%-1,39%+13,99% 115 mld.
+1,66%+0,58%+7,34%+1,71%+4,19%+4,25%+35,09%-4,56%-1,09% 100 mld.
-1,68%+0,92%+14,00%+282,71%+726,28%+812,28%+247,06%+5,40% - 101 mld.
-0,66%+5,56%+24,95%+19,44%+23,48%+39,81%+19,63%+51,00%+114,41% 96,27 mld.
+0,03%+3,67%+18,76%+0,51%-13,28%-4,96%+52,80%+73,83%+550,80% 73,55 mld.
-2,28%-1,46%+6,85%+5,82%+20,84%+28,05%-1,69%-30,77%+56,05% 73,13 mld.
Gemiddelde +0,29%-0,30%+12,04%+24,61%+55,66%+64,36%+62,70%+89,37%+271,60% 279 mld.
Gewogen gemiddelde per kap. +0,60%+0,02%+12,92%+18,33%+39,91%+47,28%+83,26%+165,34%+556,84%
  1. Beurs
  2. Aandelen
  3. Koers VRTX
  4. Sector Vertex Pharmaceuticals Incorporated